Hazard characterization of silver nanoparticles for human exposure routes

Abstract

Silver nanoparticles (AgNPs) have been widely used for a multitude of applications without full comprehensive knowledge regarding their safety. In particular, lack of data on hazard characterization may lead to uncertainties regarding potential human health risk. To provide the foundation for human health risk assessment of AgNPs, this study evaluates existing hazard characterization data, including reported pharmacokinetics, symptoms, and their corresponding dose-response relationships. Human equivalent relationships are also provided by extrapolation from animal dose-response relationships. From the data analyzed, it appears that AgNPs may persist for long periods (from days to years) in the human body. It was found that AgNP toxicity on traditional major targets of exogenous substances were generally underestimated. Some omissions of toxicity on sensitive systems in the AgNP toxicity assessment require attention, such as reprotoxicity and neurotoxicity. The necessity of the establishment of toxicity tests specifically for nanomaterials is highlighted. The scientific basis of a toxicity testing strategy is advised by this study, which paves the way for the monitoring and regulation of the ENP utilization in various industries.

Keywords:

• silver nanoparticle
• nanotoxicity
• in-vivo
• dose-response relationship
• hazard characterization

Acknowledgement

The support of the China Scholarship Council (CSC) is highly appreciated.

Additional information

Funding

The authors would like to acknowledge China Scholarship Council (CSC) and University College Dublin (UCD) for supporting this study under CSC-UCD Scheme.